Carregant...
Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
Cancer drug screening in patient‐derived cells holds great promise for personalized oncology and drug discovery but lacks standardization. Whether cells are cultured as conventional monolayer or advanced, matrix‐dependent organoid cultures influences drug effects and thereby drug selection and clini...
Guardat en:
| Publicat a: | Mol Syst Biol |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731348/ https://ncbi.nlm.nih.gov/pubmed/29180611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/msb.20177697 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|